Literature DB >> 25957664

Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan.

Koji Ishii1, Tomoko Kiyohara2, Sayaka Yoshizaki2, Kunio Kawabata3, Atsuhiro Kanayama3, Yuichiro Yahata3, Takuri Takahashi3, Hitomi Kinoshita3, Takehito Saitou3, Tomimasa Sunagawa3, Kazunori Oishi3, Masashi Uema4, Mamoru Noda4, Takaji Wakita2.   

Abstract

Hepatitis A virus (HAV) is one of the most common causes of feces-transmitted acute hepatitis worldwide. In Japan, most of HAV infections have been sporadic cases and a relatively low number of cases (approximately 100-150) of acute hepatitis A were reported in 2012 and 2013. However, in 2014, 342 cases were reported as of week 22. In order to characterize the viral agents causing this outbreak, we collected stool or sera (and both for three case) from patients with hepatitis A from many regions throughout Japan and performed genotyping of the VP1/P2A regions of HAV. We then used a multiple-alignment algorithm to compare the nucleotide sequences with those of reference strains. Phylogenetic tree analyses revealed that the 159 HAV isolates were divided into three subgenotypes: IA (137 cases), IB (4 cases), and IIIA (18 cases). The most unique feature of this outbreak was that for most subgenotype IA cases (103 out of 137 IA cases) the sequences analyzed shared 100% homology. Interestingly, the peak week for these IA infections was almost the same nationwide, suggesting that the epidemic of hepatitis A caused by this subgenotype IA strain may have expanded from a single source possibly because of one food-borne or waterborne source that was distributed nationwide at once.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genotype; Hepatitis A virus; Outbreak; Phylogenetic analysis

Mesh:

Substances:

Year:  2015        PMID: 25957664     DOI: 10.1016/j.vaccine.2015.04.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.

Authors:  Chengkai Yu; Yufei Song; Yangyang Qi; Chanjuan Li; Zhiwei Jiang; Chen Li; Wei Zhang; Ling Wang; Jielai Xia
Journal:  Hum Vaccin Immunother       Date:  2016-07-06       Impact factor: 3.452

3.  Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.

Authors:  Yu-Lin Lee; Kuan-Yin Lin; Chien-Yu Cheng; Chia-Wen Li; Chia-Jui Yang; Mao-Song Tsai; Hung-Jen Tang; Te-Yu Lin; Ning-Chi Wang; Yi-Chien Lee; Shih-Ping Lin; Yu-Shan Huang; Hsin-Yun Sun; Jun-Yu Zhang; Wen-Chien Ko; Shu-Hsing Cheng; Yuan-Ti Lee; Chun-Eng Liu; Chien-Ching Hung
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

4.  Fatal acute hepatic failure in a family infected with the hepatitis A virus subgenotype IB: A case report.

Authors:  Yuichi Yoshida; Yohei Okada; Akiko Suzuki; Keisuke Kakisaka; Yasuhiro Miyamoto; Akio Miyasaka; Yasuhiro Takikawa; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

5.  Surveillance of Hepatitis Viruses in Several Small Islands of Japan by Ship: A Public Health Approach for Elimination of Hepatitis Viruses by 2030.

Authors:  Tomohiro Akao; Morikazu Onji; Keitarou Kawasaki; Takahide Uehara; Yukima Kuwabara; Takashi Nishimoto; Shinji Yamamoto; Jiro Miyaike; Masaki Oomoto; Teruki Miyake
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jul-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.